Daniel J. Gruskin

Nessuna posizione attualmente

52 anni

Health Technology

Consumer Services

Profilo

Daniel J.
Gruskin worked as Vice President & Head-Global Medical Affairs at Genzyme Corp.
and as an Assistant Professor at Emory University School of Medicine.
He also served as the Chief Medical Officer at LogicBio Therapeutics, Inc. from 2021 to 2022.

Precedenti posizioni note di Daniel J. Gruskin

Società	Posizione	Fine
LOGICBIO THERAPEUTICS, INC.	Direttore Tecnico/Scientifico/R&S	16/11/2022
Emory University School of Medicine	Corporate Officer/Principal	-
Genzyme Corp. Genzyme Corp. Medical SpecialtiesHealth Technology Genzyme Corp. engages in development and manufacture of specialty therapeutic, surgical and diagnostic product. It serves in the areas of rare genetic diseases, multiple sclerosis, cardiovascular diseases and endocrinology. The company was founded on June 8, 1981 and is headquartered in Cambridge, MA.	Corporate Officer/Principal	-

Vedi nel dettaglio l'esperienza di Daniel J. Gruskin

Esperienze
Posizioni ricoperte

Attive

Inattive

Società quotate in Borsa

Aziende private

Vedi nel dettaglio l'esperienza di Daniel J. Gruskin

Relazioni

Relazioni di 1° grado

Aziende connesse in 1º grado

Uomo

Donna

Amministratori

Dirigenti

Vedi i contatti personali

Società collegate

Aziende private	2
LogicBio Therapeutics, Inc. LogicBio Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology LogicBio Therapeutics, Inc. engages in the development of a genome editing technology platform. It focuses on the commercialization of GeneRide, which enables the site-specific integration of a therapeutic transgene without nucleases or exogenous promoters by harnessing the native process of homologous recombination. Its pipeline includes LB-001, LB-301 and LB-401. The company was founded by Mark A. Kay, Leszek Lisowski, and Adi Barzel in August 2014 and is headquartered in Lexington, MA.	Health Technology
Genzyme Corp. Genzyme Corp. Medical SpecialtiesHealth Technology Genzyme Corp. engages in development and manufacture of specialty therapeutic, surgical and diagnostic product. It serves in the areas of rare genetic diseases, multiple sclerosis, cardiovascular diseases and endocrinology. The company was founded on June 8, 1981 and is headquartered in Cambridge, MA.	Health Technology